2016
DOI: 10.5812/ircmj.21577
|View full text |Cite
|
Sign up to set email alerts
|

Contovir - A New Adjuvant Therapy in Recurrent Respiratory Papillomatosis: A Case Study

Abstract: Background: Contovir is a mixture of herbal extracts (Tanacetum vulgare, Rossa canina, Urtica dioica) that is supplemented with selenium. Objectives: This study aimed to add Contovir to the classic treatment of recurrent respiratory papillomatosis (RRP) in order to decrease the severity and extent of the disease, elongate the surgical intervals and improve the sense of patient well-being. Furthermore, we had to adjust the prescribed drug dosage, since there were no previous findings available. Patients and Met… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…When the juvenile-RRP group was assessed separately, the age at the time of diagnosis ranged between 1 and 12 years old, as shown in Table 3. Most patients (62.5%) (10) were diagnosed up to their fifth year of life, and 37.5% (7) were diagnosed after six years of age.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…When the juvenile-RRP group was assessed separately, the age at the time of diagnosis ranged between 1 and 12 years old, as shown in Table 3. Most patients (62.5%) (10) were diagnosed up to their fifth year of life, and 37.5% (7) were diagnosed after six years of age.…”
Section: Resultsmentioning
confidence: 99%
“…According to the patient's age, RRP can be classified as juvenile-RRP when it occurs in individuals aged ≤12 years old and adult-RRP when it affects individuals aged >12 years 7,8 . Juvenile-RRP is generally more aggressive due to the rapid growth of multiple lesions with possible airway obstruction, recurrence and metastasis 2,9 .…”
Section: Introductionmentioning
confidence: 99%